First-in-human Clinical Trial of a Novel Eyelid warming Device in Meibomian Gland Dysfunction

CONCLUSIONS: In this first study of a novel eyelid warming device, overall subjective satisfaction was reported in 80% of patients. Potential advantages of this user-friendly device include its ability to improve MGD and tear film stability, as well as symptomatic relief, while allowing the user to continue with normal daily functioning while undergoing treatment.PMID:38420642
Source: The Israel Medical Association Journal - Category: General Medicine Authors: Source Type: research